文献速递认知障碍与痴呆

临床样本中[18F]AV1451 tau PET与脑脊液tau病理标志物的关联

Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.
PubMed 文献 · Neurology · 2017-12-27

结果显示两者鉴别AD与非AD的AUC均为0.92-0.94,分类一致率达83%,在异质临床组中相关性强,但在AD内相关性减弱。

要点

  • CSF p-tau与[18F]AV1451 PET对Aβ阳性AD与非AD的鉴别效能相当(AUC 0.92-0.94)。
  • 全样本中皮层[18F]AV1451与CSF p-tau相关性最强(r=0.75)。
  • AD患者内[18F]AV1451与CSF p-tau/t-tau相关性减弱(r=0.46)。

核心结论

  • [18F]AV1451-PET与脑脊液p-tau在鉴别诊断中具有相当价值,但在AD内相关性减弱,提示液体与影像标志物捕捉tau病理的不同方面。
  • 在异质性临床组中相关性稳健,但在AD患者中虽仍显著但相关性减弱。

研究设计与样本

  • 脑脊液Aβ42、t-tau和p-tau通过多分析物免疫测定(AlzBio3)测量。
  • 采用受试者工作特征分析比较标志物对Aβ阳性AD与非AD的鉴别能力,使用跳跃Pearson相关系数评估CSF与PET SUVR的相关性,并进行体素分析。

主要发现

  • [18F]AV1451-PET皮层SUVR和p-tau区分Aβ阳性AD与非AD的AUC为0.92-0.94,其他CSF指标AUC≤0.83,分类一致率达83%。
  • 全样本中皮层[18F]AV1451与所有CSF标志物相关,与p-tau相关性最强(r=0.75),t-tau为0.57,Aβ42为-0.49。
  • 在Aβ阳性AD患者中,[18F]AV1451 SUVR与p-tau和t-tau中度相关(均r=0.46),与Aβ42不相关(r=0.02)。
  • 体素分析显示[18F]AV1451与CSF p-tau在颞顶叶皮层相关,与t-tau在内侧前额区域相关。
  • 在AD患者中,简易精神状态检查评分与[18F]AV1451-PET相关,但与CSF标志物不相关。

关键数值与推荐

  • Aβ阳性AD与非AD鉴别的AUC:[18F]AV1451-PET和p-tau为0.92-0.94,其他CSF指标≤0.83。
  • 全样本中[18F]AV1451与CSF p-tau的相关系数r=0.75,t-tau r=0.57,Aβ42 r=-0.49。
  • Aβ阳性AD患者中[18F]AV1451与p-tau和t-tau的相关系数均为r=0.46,与Aβ42 r=0.02。

临床怎么用

  • 在临床异质性样本中,CSF p-tau和[18F]AV1451 PET均可用于区分AD与非AD神经退行性疾病。
  • 液体与影像tau标志物可能提供互补信息,尤其在不同疾病阶段或病理方面。

局限性

  • AD患者中影像与液体标志物相关性减弱,具体机制未明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the relationships between fluid and imaging biomarkers of tau pathology and compare their diagnostic utility in a clinically heterogeneous sample. METHODS: Fifty-three patients (28 with clinical Alzheimer disease [AD] and 25 with non-AD clinical neurodegenerative diagnoses) underwent β-amyloid (Aβ) and tau ([18F]AV1451) PET and lumbar puncture. CSF biomarkers (Aβ42, total tau [t-tau], and phosphorylated tau [p-tau]) were measured by multianalyte immunoassay (AlzBio3). Receiver operator characteristic analyses were performed to compare discrimination of Aβ-positive AD from non-AD conditions across biomarkers. Correlations between CSF biomarkers and PET standardized uptake value ratios (SUVR) were assessed using skipped Pearson correlation coefficients. Voxelwise analyses were run to assess regional CSF-PET associations. RESULTS: [18F]AV1451-PET cortical SUVR and p-tau showed excellent discrimination between Aβ-positive AD and non-AD conditions (area under the curve 0.92-0.94; ≤0.83 for other CSF measures), and reached 83% classification agreement. In the full sample, cortical [18F]AV1451 was associated with all CSF biomarkers, most strongly with p-tau (r = 0.75 vs 0.57 for t-tau and -0.49 for Aβ42). When restricted to Aβ-positive patients with AD, [18F]AV1451 SUVR correlated modestly with p-tau and t-tau (both r = 0.46) but not Aβ42 (r = 0.02). On voxelwise analysis, [18F]AV1451 correlated with CSF p-tau in temporoparietal cortices and with t-tau in medial prefrontal regions. Within AD, Mini-Mental State Examination scores were associated with [18F]AV1451-PET, but not CSF biomarkers. CONCLUSION: [18F]AV1451-PET and CSF p-tau had comparable value for differential diagnosis. Correlations were robust in a heterogeneous clinical group but attenuated (although significant) in AD, suggesting that fluid and imaging biomarkers capture different aspects of tau pathology. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that, in a clinical sample of patients with a variety of suspected neurodegenerative diseases, both CSF p-tau and [18F]AV1451 distinguish AD from non-AD conditions.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. La Joie R, Bejanin A, Fagan AM, et al. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. 2017. PMID: 29282337. doi:10.1212/WNL.0000000000004860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。